When I speak to clinical executives from large pharma companies, they always seem to be interested in the trending topics of the day. Those topics might include AI and machine learning, blockchain, real-world evidence, adaptive trials, and more. When I speak to executives from small pharma and biotech companies, the conversations are very different. Their interests lie in what you might call the basics of clinical trials. Those basics include selecting and overseeing sites, CRO oversight, and patient recruitment. One of the greatest challenges for those companies always seems to be CRO selection.
Aside from the difficult decision of whether to select a large or small CRO, sponsors grapple with CRO location, international presence, and culture. Of course, another primary concern is the quality of the team you will be working with and whether they will provide you with the attention you need.
The articles in this e-book all relate to the challenge of CRO selection. I hope you enjoy them and learn from the insights contained in them. I wish you the best of luck in selecting your next outsourcing partner.
- Ed Miseta, Chief Editor, Clinical Leader